ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
1,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1,8,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3,1,Application site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3,2,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
4,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4,2,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
4,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4,4,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
4,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4,7,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5,2,Nail bed tenderness,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
6,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
6,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
7,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
8,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
8,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
8,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
10,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
11,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
11,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
12,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
13,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
13,2,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
13,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
13,4,Tissue injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
13,5,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
14,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
15,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
16,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
17,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
18,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
18,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
19,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
19,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
20,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
